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Abstract Rabphilin is a synaptic vesicle-associated protein
proposed to play a role in regulating neurotransmitter release.
Here we report the isolation and identi¢cation of a novel protein
complex containing rabphilin, annexin A4 and synaptotagmin 1.
We show that the rabphilin C2B domain interacts directly with
the N-terminus of annexin A4 and mediates the co-complexing
of these two proteins in PC12 cells. Analyzing the cellular local-
isation of these co-complexing proteins we ¢nd that annexin A4
is located on synaptic membranes and co-localises with rabphilin
at the plasma membrane in PC12 cells. Given that rabphilin and
synaptotagmin are synaptic vesicle proteins involved in neuro-
transmitter release, the identi¢cation of this complex suggests
that annexin A4 may play a role in synaptic exocytosis.
( 2004 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Regulated exocytosis is triggered by intracellular Ca2þ ele-
vation and because Ca2þ elevation is critical in steps preceding
vesicle fusion, it is important to identify components acting as
and through Ca2þ sensors. One possible Ca2þ sensor involved
in the regulation of exocytosis is rabphilin. This protein, like
other proposed Ca2þ sensors, contains C2 (conserved region
2) domains. C2 domains were originally identi¢ed in protein
kinase C isoforms displaying Ca2þ-dependent membrane as-
sociation properties [1]. C2 domains are structural modular
units containing approximately 120 amino acids [2] that
were initially proposed to be Ca2þ-dependent phospholipid
binding units [3]. However, since then, evidence has accumu-
lated to suggest that C2 domains may also play an important
role in mediating protein^protein interactions [4^6]. These
protein^protein interactions in turn may be involved in a
wide range of intracellular signal transduction events.
In order to identify molecular mechanisms involved in exo-
cytosis, we have looked for protein^protein interactions medi-
ated by the C2 domains of rabphilin. Structurally, the full-
length rabphilin protein contains an N-terminal rab3 interac-
tion domain [7,8], a central phosphorylation region [9,10] and
two C2 domains (denoted C2A and C2B) located in the C-
terminal tail which bind phospholipids in a Ca2þ-dependent
manner [11]. It is expressed in neuronal and neuroendocrine
cells and has been shown to localise to synaptic vesicles and
dense-core secretory granules [12,13]. On the basis of its in-
teraction with GTP-bound (activated) rab3a it has been pro-
posed to be an e¡ector for this G protein [14]. However,
increasing evidence suggests that rabphilin can vesicle-associ-
ate and function independently of rab3 proteins [13,15^19]
and it has been shown to be a rab27a interaction protein
[20]. Furthermore, previous work suggests that the C2B do-
main of rabphilin may be important for the protein’s ability to
regulate exocytosis [12,21]. However, the molecular mecha-
nism for this activity has yet to be determined. Unlike pro-
teins such as synaptotagmin, potential binding partners for
rabphilin C2 domains have been little studied. However, L-
adducin has been shown to bind to a rabphilin fragment con-
taining amino acids 281^704. This region encompasses both
C2 domains, but this interaction has only been demonstrated
in vitro by overlay assay and requires the presence of lipids
and Ca2þ [22]. In addition, neurexin has been shown to bind
to a synaptotagmin-like motif located in the amino acid re-
gion 674^696 of rabphilin. However, it is unlikely that neu-
rexin would bind to the C2B region alone since it does not
contain amino acids 691^696 which appear to be critical for
stable interaction to occur [23].
Therefore, in order to elucidate a signalling role for this C2
domain, we have looked for protein complex formations. In
this study we report the isolation of a novel protein complex
formed by the C2B domain of rabphilin and the identi¢cation
of key protein components in this complex.
2. Materials and methods
2.1. Glutathione S-transferase (GST) fusion proteins and isolation of
protein complexes
cDNA fragments encoding the C2A (amino acids 371^510) and
C2B domains (528^684) of rat and the 14 amino acid N-terminal
sequence of annexin A4 were subcloned into the pGEX GST fusion
protein system and proteins expressed and puri¢ed as previously de-
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scribed by us [5,24]. Cleavage of the rabphilin C2B domain from the
GSTC2B protein was performed using thrombin digestion [24]. Rat
brain synaptosomes were prepared as previously described [25]. Syn-
aptosomal proteins were solubilised by homogenisation in phosphate-
bu¡ered saline (PBS) containing 1% (v/v) Triton X-100 and 100 WM
Ca2þ followed by centrifugation at 20 000Ug. GST fusion proteins
(100 nM) bound to glutathione agarose beads were incubated for 1 h
with synaptosome supernatants. Protein complexes were collected by
centrifugation and washed three times with PBS. Co-complexed pro-
teins were then labelled with normal horse serum (NHS)-biotin and
blots analysed as previously described by us [5]. For scaled-up proce-
dures, rat brains were homogenised and centrifuged as before and
supernatants collected and incubated overnight with 100 nM
GSTC2B. Complexes were then washed with RIPA bu¡er [5], proteins
separated by sodium dodecyl sulfate^polyacrylamide gel electrophore-
sis (SDS^PAGE) and detected by Coomassie blue staining.
2.2. Annexin A4 N-terminal tail Vp22 fusion protein (Vp22NT)
construction
Oligonucleotides corresponding to the sense and antisense strands
of DNA encoding the ¢rst 14 amino acids of the rat annexin A4
sequence were ligated into the pCRT7/VP22/NES-2 TOPO vector (In-
vitrogen), expressed and puri¢ed as per the instruction manual (Invi-
trogen).
2.3. Peptide preparation and mass spectrometric analysis
Protein bands from scaled-up puri¢cations were extracted from
stained gels using 50% acetonitrile in 50 mM ammonium bicarbonate.
After alternative washing steps with 50 mM ammonium bicarbonate
or 50% acetonitrile, the gel pieces were digested overnight at room
temperature with trypsin, 50 mM ammonium bicarbonate (pH 8.0).
Peptides were then extracted using sequential steps of 0.2% tri£uoro-
acetic acid (TFA), followed by 50% acetonitrile in 0.1% TFA. The
peptide extracts were desalted using Zip Tip C18 columns according
to the manufacturer’s protocol (Millipore) and eluted in 5 Wl of 50%
acetonitrile containing 0.1% TFA. MALDI mass spectra were re-
corded for peptide extracts using Ettan MALDI-TOF (Amersham
Biosciences), operated in an automatic acquisition method under pos-
itive ion re£ectron mode at 20 kV accelerating voltage with pulsed ion
extraction enabled. K-Cyano-4-hydroxycinnamic acid (10 mg/ml in
50% acetonitrile and 0.1% TFA) was used as the matrix. The peptide
masses obtained were searched against the National Center for Bio-
technology Information (non-redundant all taxonomies) database us-
ing the built-in program ProFound. One missed cleavage per peptide
was allowed and an initial mass tolerance of 50 ppm was used in all
searches.
2.4. Annexin A4 and rabphilin C2B pulldowns
GST fusion proteins (400 nM) were immobilised on glutathione
agarose beads and incubated in PBS in the absence or presence of
Ca2þ (100 WM) as indicated with recombinant human annexin A4
protein (1 WM) [24]. Samples were washed three times with PBS con-
taining 1% (v/v) Triton X-100 and Western blots probed with anti-
annexin A4 antibodies, followed by enhanced chemiluminescence
(ECL) detection. For rabphilin C2B pulldowns Vp22NT protein (1
WM) was incubated with GST or GSTC2B proteins (400 nM) on
beads in PBS containing 10 WM Ca2þ. Samples were collected by
Fig. 1. Isolation of proteins co-complexing with the C2 domains of
rabphilin. A: Visualisation of proteins co-complexing with rabphilin
C2 domains in rat brain synaptosomes. Co-complexed proteins were
labelled with NHS-biotin and detected using avidin-horseradish per-
oxidase and ECL. B: Scaled-up preparation of proteins co-complex-
ing with the rabphilin C2B domain in rat brain homogenates. Pro-
teins were detected by Coomassie blue staining. BH is a brain
homogenate sample prior to puri¢cation and M are molecular
weight markers.
Fig. 2. MALDI-TOF analysis of isolated proteins. A: Mass spectral analysis for p68 protein gel bands. B: Peptides recovered from p68
(showed in red). C: Mass spectral analysis for p50/55 protein gel bands. D: Peptides recovered from p50/55 samples (shown in red).
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centrifugation, washed and prepared as above. Blots were probed with
anti-myc epitope antibodies to detect for Vp22 proteins.
2.5. Overlay binding assay and in vitro peptide competition studies
For overlay binding assay, recombinant annexin A4 protein (20 Wg)
samples were loaded onto polyacrylamide gels and Western trans-
ferred. Filters were cut into individual strips and incubated overnight
with GST fusion proteins as indicated. Blots were probed with anti-
GST antibodies followed by ECL detection. For peptide competition
studies, recombinant GST annexin A4 (4 Wg) and rabphilin C2B do-
main protein (2 Wg cleaved from the GSTC2B fusion protein) were
incubated at 4‡C for 2 h in PBS containing 10 WM Ca2þ in the
presence or absence of scrambled or wild type sequence N-terminal
annexin A4 peptides (10 Wg). After washing three times with PBS
containing 1% Triton X-100, samples were analysed by SDS^PAGE
and Coomassie staining.
2.6. Cell culture and loading of PC12 cells
Mixed astrocyte^neurone cultures were prepared from 6^8 day old
Sprague^Dawley rats as previously described [41]. Cells were used for
immuno£uorescence studies after 7 days in culture. PC12 cells were
maintained in Dulbecco’s modi¢ed Eagle’s medium (DMEM) contain-
Fig. 2 (Continued).
FEBS 28027 30-1-04 Cyaan Magenta Geel Zwart
A. Willshaw et al./FEBS Letters 559 (2004) 13^21 15
ing 10% horse serum and 5% foetal bovine serum until use. PC12 cells
that were 50^70% con£uent were loaded in suspension by electropo-
ration in serum-free DMEM medium containing 100 nM fusion pro-
teins or N-terminal annexin A4 (METKGGTVKAASGF) or
scrambled (MFEGTSKAGAGKVT) peptide as previously described
by us [24].
2.7. Immuno£uorescent labelling of cells
Immunostaining was performed as previously described [26]. Spe-
ci¢cally, cells were grown on chamber slides and ¢xed in 4% formal-
dehyde. Cells were permeabilised with 0.1% Triton X-100 and blocked
in 5% donkey serum. Cells were mounted in Vectashield medium prior
to microscopic analysis.
2.8. Analysis of complex formation in synaptosomes
Synaptosome fractions were prepared as described previously [25].
Membrane and vesicle fractions were solubilised in PBS containing
1% (v/v) Triton X-100 and after collection by centrifugation at
20 000Ug supernatants were subjected to immunoprecipitation with
appropriate antibodies. Immunoprecipitations and Western blotting
procedures were as previously described by us [5].
3. Results and discussion
We began our studies attempting to isolate proteins which
co-complex with either the C2A or C2B domain of rabphilin.
Using biotin labelling, we detected six protein bands that co-
puri¢ed speci¢cally with the C2B domain: a doublet around
120/100 kDa (‘p120/p100’), a strongly labelled protein at
around 68 kDa (‘p68’), a doublet around 55/50 kDa (‘p55/
50’) and another strongly labelled protein of around 34 kDa
(‘p34’; Fig. 1A). Unfortunately, no proteins speci¢cally inter-
acting with the C2A domain were obtained under these con-
ditions (Fig. 1A). However, since biotin labelling primarily
labels lysine residues in proteins it is still possible that proteins
were co-complexing with this domain but remained unde-
tected using this procedure.
In order to obtain su⁄cient material for mass spectral iden-
ti¢cation of these proteins, the puri¢cation procedure was
then scaled up and proteins were isolated from SDS^polyac-
rylamide gels stained with Coomassie blue (Fig. 1B). MALDI-
TOF analysis allowed the successful identi¢cation of p68 and
p50/55 proteins (Fig. 2). p68 was found to be synaptotagmin 1
and samples of the puri¢ed complex were subjected to West-
ern blot probing with an antibody raised to the ¢rst 16 amino
acids of synaptotagmin I, a sequence that is unique to this
synaptotagmin isoform, and this further con¢rmed the iden-
tity of p68 (data not shown). The p50 and p55 bands were
both identi¢ed as L-tubulin. Initially we were sceptical of this
¢nd because L-tubulin is a very abundant protein in brain
homogenates. However, it was not found to purify with fusion
proteins containing the C2A domain (Fig. 1A) or GST (data
not shown) and a number of protein gel samples were ana-
lysed by MALDI-TOF. Therefore based on these criteria L-
tubulin appears to be a speci¢c interacting protein.
Unfortunately, identi¢cation of proteins below the 35 kDa
size or the p100 and p120 proteins was not possible by MAL-
DI-TOF analysis as the amount of material obtained was
insu⁄cient and probably contained a number of proteins/pep-
tides. Similarly, due to the large amounts of fusion protein
used in the scaled-up procedure, it was not possible to obtain
a discrete p34 band for analysis (Fig. 1B).
However, we rationalised that since we [5] and others [4,6]
have previously shown annexin-like proteins and annexin
family members directly interacting with proteins via their
C2 domains, there was a strong possibility that an annexin
could be present in this protein complex. In addition, since
Fig. 3. Identi¢cation of p34 as annexin A4 and veri¢cation of annexin A4^rabphilin interaction. A: Western blot probing with a range of anti-
bodies raised against annexin family members indicated that only annexin A4 was expressed in rat synaptosomes. B: Protein complexes were
isolated as described in Fig. 1A. Western-blotted samples were then probed with anti-annexin A4 antibodies to verify that p34 was annexin A4.
SL is a control lane containing synaptosome lysates to show the speci¢city of the antibody used. C: Annexin A4 and rabphilin co-immunopre-
cipitate from synaptosome lysates. Synaptosome lysates were immunoprecipitated (IP) with antibodies as indicated: anti-annexin A4 (A4), anti-
rabphilin (R), pre-immune rabbit sera (Pre). Blots were probed with either anti-rabphilin (left panel) or anti-annexin A4 antibodies (right pan-
el). Control lanes containing synaptosome lysates (SL) show speci¢city of antibodies used during probing.
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most annexin family members have a molecular weight in the
range of 32^36 kDa [27], we looked to see if p34 could be an
annexin. To do this, we initially probed synaptosome lysates
to see which annexins were expressed. Our studies indicated
that only one annexin (annexin A4) was signi¢cantly ex-
pressed in synaptosomes (Fig. 3A). We next employed West-
ern blotting and immunoprecipitation studies to see if annexin
A4 was able to co-complex with rabphilin. We found that the
34 kDa protein isolated in our small-scale puri¢cations was
detected by anti-annexin A4 antibodies (Fig. 3B) and that
annexin A4 was indeed able to co-immunoprecipitate with
rabphilin from synaptosomes (Fig. 3C). Furthermore, using
pulldown (Fig. 4A) and overlay assays (Fig. 4B), we were
able to show that the rabphilin C2B domain was able to
directly bind to annexin A4 in a Ca2þ-dependent manner.
Moreover, because the C2B domain was able to bind to a
denatured form of annexin A4 in the overlay assay, we rea-
soned that the conserved highly structured C-terminal protein
core [27,28] characteristic of this and all annexin members
may not be involved in this binding. Instead, the unique short
N-terminal tail of annexin A4 looked like a prime candidate
for binding.
Therefore, in order to test whether the rabphilin C2B do-
main interacts directly with the N-terminal tail of annexin A4
we employed another pulldown assay. This time, we incubated
GST or GSTC2B fusion proteins (immobilised on beads) with
a myc epitope-tagged recombinant annexin A4 N-terminal tail
fusion protein (termed Vp22NT). We found that this annexin
A4 N-terminal sequence was indeed able to bind to the rab-
philin C2B domain (Fig. 4C). Next, we reasoned that if this
N-terminal annexin A4 sequence is important for the rabphi-
lin^annexin A4 interaction to occur in cells, then we should be
able to disrupt the interaction of native proteins by loading a
peptide corresponding to this N-terminal tail sequence. Using
PC12 cells (since these endogenously express both rabphilin
and annexin A4 proteins) we loaded either the wild type 14
amino acid sequence peptide or a control scrambled sequence
peptide by electroporation. After cell recovery, co-immuno-
precipitation studies and Western blotting were undertaken
to detect rabphilin and annexin A4 co-complexing (Fig.
4D). We found that the loading of annexin A4 peptide (com-
pared to scrambled control peptide) resulted in a signi¢cant
reduction of the amount of annexin A4 co-complexing with
rabphilin (by approximately 50%). In addition, we have
undertaken an in vitro peptide competition assay, where we
incubated recombinant GST annexin A4 and the rabphilin
C2B domain in the presence or absence of excess scrambled
and wild type sequence peptides and again blocked the annex-
in A4^rabphilin interaction with the wild type sequence pep-
tide (Fig. 4E). Hence, we conclude that this N-terminal an-
nexin A4 sequence does have the ability to interact directly
with the C2B domain, but our results do not preclude the
Fig. 4. The N-terminal tail of annexin A4 binds directly to the C2B domain of rabphilin. A: Annexin A4 pulldowns. GST fusion proteins were
incubated as indicated with recombinant human annexin A4 protein (1 WM) in the absence or presence of Ca2þ (100 WM). Samples were West-
ern-blotted and probed for the presence of annexin A4. B: Overlay (far Western) binding of fusion proteins to recombinant annexin A4. An-
nexin A4 protein (20 Wg) was loaded onto gels and Western-transferred. Blots were incubated with GST fusion proteins as indicated and
probed for fusion protein binding with anti-GST antibodies. C: Rabphilin C2B pulldowns using Vp22NT fusion protein. A Vp22 fusion protein
containing the N-terminal tail sequence from annexin A4 was incubated with either GST or GSTrabphilinC2B (C2B) proteins. Samples were
Western-blotted and blots probed with anti-myc antibodies to detect Vp22 fusion protein bound. D: Loading PC12 cells with wild type annexin
A4 N-terminal tail peptide (A4) but not the scrambled sequence peptide (Con) inhibits the ability of rabphilin to co-complex with annexin A4
as assessed by anti-rabphilin immunoprecipitations. Cell lysates were immunoprecipitated with anti-rabphilin antibodies and samples were then
Western-blotted and the blots probed with either anti-rabphilin (upper panel) or anti-annexin A4 (lower panel) antibodies. E: In vitro blocking
of annexin A4^rabphilin C2B interaction with wild type (A4) or scrambled (Con) annexin A4 N-terminal sequence peptides. Lanes 1^3:
GSTannexin A4 and rabphilin C2B pulldowns in the absence (lane 1) or presence (lanes 2 and 3) of peptides as indicated. Lanes 4 and 5 are
control lanes showing recombinant proteins used: GSTannexin A4 (lane 4) and rabphilin C2B (lane 5).
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Fig. 5.
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possibility that other regions of the annexin protein may also
interact with the rabphilin protein in vivo.
This protein sequence within the N-terminal region is
unique for this annexin family member and is believed to
form an extension that lies across the concave (cytosol-facing)
surface of the protein [29]. It is therefore conceivable that
when annexin A4 is bound to the inner surface of the plasma
membrane this tail region would still be available for highly
speci¢c protein^protein interactions to occur at the cytosolic
surface. This tail region has also been proposed to play a role
in regulating annexin A4 multimerisation [30] and in common
with annexins A1 and A2 could play an important role in the
Ca2þ sensitivity and cellular localisation of the protein [27,31^
34].
Since, to our knowledge, annexin A4 has not previously
been studied in synaptosomes, we probed for the localisation
of this protein in synaptosomes. To do this we fractionated
synaptosomes by centrifugation as previously described [25]
and probed for the presence of annexin A4 in each fraction.
We found that annexin A4 was only detected in synaptosome
membranes and not in puri¢ed vesicle fractions (Fig. 5A).
Furthermore, by probing synaptosome fractions with the pre-
synaptic marker proteins rabphilin, synaptotagmin-I and syn-
aptophysin, we have characterised our synaptosomal prepara-
tions (Fig. 5B). However, since presynaptic proteins are also
found in astrocytes and annexin A4 has previously been re-
ported to be found in glial cells in human hippocampus [34] it
was conceivable that glial cell membranes could be present in
our cortical synaptosome preparations. So, we probed synap-
tosomes with an antibody raised against a glial cell-speci¢c
protein glial ¢brillary acidic protein (GFAP) and indeed we
did detect some glial cell contamination (data not shown).
Therefore, in order to determine whether annexin A4 was
expressed and co-complexed with rabphilin and synaptotag-
min in glial cells we undertook immuno£uorescence studies
using primary cortical neuronal cultures (Fig. 5C). Dual stain-
ing for GFAP and annexin A4 showed that annexin A4 gave a
discrete punctate staining pattern and did not co-localise with
glial cells and therefore annexin A4 is most probably ex-
pressed in nerve terminals (synaptosomes). In addition, we
Fig. 5. Localisation of complex formation in synaptosomes, neuronal cultures and PC12 cells. A: Fractionation of synaptosomes. Equal pro-
portions of membranes (M), vesicle (V) and cytosolic (C) fractions or whole synaptosomes (W) were loaded and probed by Western blotting
with anti-annexin A4 antibodies. B: Synaptosome fractions (as de¢ned in A) were probed for the presence of rabphilin (top panel), synaptotag-
min-1 (middle panel) and synaptophysin (bottom panel). C: Rat primary cortical neuronal cultures were stained for either the glial cell-speci¢c
protein GFAP (FITC green), or annexin A4 (Texas red). D: Annexin A4 and rabphilin co-localise at the membrane periphery in PC12 cells.
Rabphilin is labelled with FITC green, annexin A4 with Texas red and co-localised proteins appear yellow (dual green and red detection).
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also probed synaptosomal preparations for L-tubulin, and we
were not able to detect its presence.
Furthermore, we have used the PC12 cell system in order to
visualise the pattern of co-localisation of rabphilin and annex-
in A4 in a whole cell system that endogenously expresses
annexin A4 and presynaptic proteins. These cells allow the
visualisation of discrete plasma membrane and (punctate)
vesicle structures (Fig. 5D). Although this cell system is
non-neuronal, it is a recognised model for regulated exocyto-
sis, and the molecular mechanisms of release are believed to
be analogous to those occurring in nerve terminals. Our im-
muno£uorescence studies con¢rmed that annexin A4 only dis-
played a plasma membrane distribution, whilst rabphilin was
found to display a predominantly punctate distribution both
at the plasma membrane and internally within cells (Fig. 5D).
The co-localisation of annexin A4 and rabphilin was only
observed at plasma membrane peripheral regions and the pat-
tern of co-staining was clearly punctate, most probably indi-
cative of vesicular staining.
Finally, to complete these studies, we went back into the
synaptosome system and probed for co-complexing of rabphi-
lin, annexin A4 and synaptotagmin in synaptic vesicle and
membrane fractions (Fig. 6). We found that rabphilin and
synaptotagmin co-complexed together with annexin A4 in
the membrane fraction. In addition, in the synaptic vesicle
fraction, rabphilin and synaptotagmin were still found to
co-complex. These data together indicate that rabphilin and
synaptotagmin must co-complex on vesicles independently of
rabphilin’s interaction with annexin A4 at the membrane (and
indeed independently of L-tubulin since this protein is absent
from synaptosomes). Therefore, we would speculate that the
potential function of these proteins co-complexing with an-
nexin A4 could be to facilitate membrane binding of rabphi-
lin/rabphilin-associated vesicles. Such a process, in turn, could
then play a role in the regulation of neurotransmitter release.
Work is now under way to see if annexin A4 plays a func-
tional role in regulated exocytosis. Although annexin A4 has
previously been postulated to function as a modulator of
chloride channels [35], a role for annexin A4 in exocytosis
would not be unprecedented. Indeed, annexin A4, in common
with a number of other annexin family members, has previ-
ously been proposed to play a role in phospholipid vesicle
association and fusion events in mammalian and yeast cell
systems [36^40]. Whether such a functional role can be attrib-
uted to this protein complex has yet to be established.
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